← Back to Search

Other

Alcohol for Alcohol Consumption (SEA Trial)

Phase < 1
Waitlist Available
Led By Harriet de Wit
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the length of the conversation (45 min)
Awards & highlights

SEA Trial Summary

This trial looks at how moderate alcohol affects feelings and connection during social situations.

SEA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the length of the conversation (45 min)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the length of the conversation (45 min) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
facial emotional responses
self-reported feelings of connection

SEA Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: placebo-alcoholExperimental Treatment1 Intervention
participant receives placebo and conversation partner receives alcohol
Group II: alcohol-placeboExperimental Treatment1 Intervention
participant receives alcohol and conversation partner receives placebo
Group III: Alcohol-alcoholExperimental Treatment1 Intervention
Both conversation partners receive alcohol
Group IV: placebo-placeboPlacebo Group1 Intervention
Both conversation partners receive placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol
2008
Completed Phase 3
~2000
Placebo
1995
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,001 Previous Clinical Trials
817,693 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,551 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,556 Total Patients Enrolled

Media Library

Alcohol (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05826951 — Phase < 1
Alcohol Consumption Research Study Groups: Alcohol-alcohol, placebo-placebo, alcohol-placebo, placebo-alcohol
Alcohol Consumption Clinical Trial 2023: Alcohol Highlights & Side Effects. Trial Name: NCT05826951 — Phase < 1
Alcohol (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826951 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a way for me to become involved in this medical experiment?

"This clinical trial is seeking 36 participants who consume alcohol and fit within the age range of 21-35. Of course, meeting these requirements is essential to secure a spot in this study."

Answered by AI

Does this research project accept participants aged forty and over?

"This trial only looks for participants ages 21 to 35 years old. Conversely, 19 clinical studies cater to the younger demographic and 177 trials are available for those above retirement age."

Answered by AI

Are there still opportunities for people to participate in this experiment?

"Per information on clinicaltrials.gov, this investigation is still recruiting participants and was initially posted to the website on February 20th of 23 and most recently updated April 11th of the same year."

Answered by AI

How many total participants is this clinical trial limited to?

"Affirmative. Per the details available on clinicaltrials.gov, this study is still open to participants, having been first posted on February 20th of 2023 and last edited April 11th of that same year. This trial requires 36 individuals to be enrolled at a single site."

Answered by AI
~17 spots leftby Apr 2025